SA Interview + SOH Interview26 May 2021 21:04
Hi,
I have recorded a lengthy interview today with Stephen OβHara, CEO of OptiBiotix Health Plc (OPTI).
We covered a lot of ground in the 111 minutes we chatted.
Highlights:
Nasdaq
SBTX dividend
Probiotics
Prebiotics
Modulation (designer pre-probiotics)
Valuations
Corporate strategy
New exciting large product launches
SweetBiotix (it is already out there in products being consumer tested - just not in the UK)
Scientific papers and their significance
NDAβs
and much, much more!
SkinBioTherapeutics news has significantly derisked the company, and that of the 23% held by OptiBiotix. I think there is a general misunderstanding of the data, even though it was presented in easy to understand form. The short version is the company has a significantly valuable probiotic which 2/3rd of the participants reported material, measurable improvements in all key areas it was designed to aid. The product will be launched in Q3-4 this year.
I am not going to go into any detail because Stuart Ashman has promised me an interview, possibly this Friday. TBC.
Both interviews will be available to paid subscribers. Stephen OβHaraβs will be available either later this evening, subject to technical issues (this being Manchester United being a distraction) or early in the evening.
I will update you on the interview with Stuart ASAP.
I will add one comment on what another blogger reported today about OptiBiotix suppressing the share price until investors know the plans for the remainder of the 23% it holds.
Each sale OPTI has done has resulted in the shares being placed in safe hands. The only exception to this being when SP Angle lied and deceived Stephen OβHara. All other placements have not had a depressing or even a suppressing effect on the shares.
https://smallcompanychampiona88.substack.com/publish